Cumberland Pharmaceuticals CPIX Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cumberland Pharmaceuticals's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cumberland Pharmaceuticals's total current liabilities?
- Cumberland Pharmaceuticals (CPIX) reported total current liabilities of $34.49M in Q1 2026.
- How has Cumberland Pharmaceuticals's total current liabilities changed year-over-year?
- Cumberland Pharmaceuticals's total current liabilities increased by 35.1% year-over-year, from $25.52M to $34.49M.
- What is the long-term trend for Cumberland Pharmaceuticals's total current liabilities?
- Over 5 years (2020 to 2025), Cumberland Pharmaceuticals's total current liabilities has grown at a 7.4% compound annual growth rate (CAGR), from $25.67M to $36.74M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.